Building tomorrow's antibody-drug conjugates (ADCs) Araris Biotech AG is pioneering a novel linker technology for antibody-drug conjugates (ADCs.) Our linker platform enables the attachment of any payload to ‘off the shelf’ antibodies without the need of prior antibody engineering. Antibody Drug Conjugates and ADCs

5 similar entities Type: Startup Activities: biotech deeptech Technologies: SaaS

Accelerating CNS Clinical Trials We’re developing faster, more effective tools to help our partners solve the biggest healthcare challenges in neurodegeneration and psychiatry. Cumulus Neuroscience has created a next-generation integrated physiological and digital biomarker platform. In clinical trials it provides the critical data and insights needed to accelerate the delivery of more effective CNS drugs to patients. This addresses the significant unmet need for faster, more robust and cost-effective execution and evaluation of clinical trials in neuroscience.

2 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology Data Analytics

Connecting People for Better Health Founded in 2003, RCA Factory is a digital public relations, corporate communications and social marketing agency. RCA Factory is at the digital convergence of communication professions. Its operation as an extended agency network of expertise allows it to adapt to the needs of clients while always striving to incorporate innovation into each operation. The agency based in Paris and London creates social media and builds public relations strategies around the possibilities offered by information technologies. She has developed particular know-how in the field of health. She puts her medical expertise at the service of regulated …

Type: SMB Activities: consulting martech

The mastermind nexus behind the corporate knowledge and intelligence of the Deep Knowledge Group. DeepTech industry analytics, benchmarking and forecasting renowned for its analytics and strategic consulting services on AI and DeepTech. Its Pharma Division is the leading provider of deep industry intelligence for the AI in Pharma sector. AI, artificial intelligence, big data, DeepTech, FinTech, data science, machine learning, GovTech, InvestTech, Blockchain, drug discovery, pharma, longevity, aging, healthspan, geroscience, agetech, preventive medicine, big data analysis, and data

103 similar entities Type: Startup Activities: it services Technologies: A.I. Data Analytics Blockchain/Cryptocurrency A.I. - Machine Learning

A Trusted Partner of Life Sciences Research and Biopharmaceutical Manufacturing | #SimplifyingProgress Sartorius is a leading international partner of biopharma research and manufacturing. We help our customers simplify progress from drug discovery to manufacturing so that more people can have access to better medicine. And simplifying progress starts with our employees who move things forward by realizing ambitious ideas and growing alongside with the company. Our product portfolio covers two customer groups: With innovative laboratory instruments and consumables, Sartorius focuses on laboratories performing research and quality control at pharmaceutical and biopharmaceutical companies as well as academic research institutes. Our broad …

Type: Large company

The World's Largest Customer Research Company. Analytics | Research | Consulting IndustryARCTM was started by a group of young, passionate professionals along with extensively experienced industry veterans across various business segments and focused expertise in the field of analytics, market research and consulting. Each professional has expertise in diverse fields like Healthcare, Chemicals, Manufacturing, Logistics, Electronics and Automotive. However diverse the expertise maybe, everyone in our team shares one common trait, we love data and we love providing solutions to clients using that data even more! Seeing your business flourish based on our solutions and strategy is what we love …

Type: Media

Part of Quantinuum | A global leader in quantum software and quantum algorithms Cambridge Quantum (CQ), part of Quantinuum, is a quantum computing software and algorithms company, and in essence we solve one critical problem – to allow our customers to get the most out of quantum computers and make them useful both now and in the future. Our focus is in the areas of quantum chemistry, quantum machine learning, quantum natural language processing and quantum cybersecurity. Quantum Computing, Quantum Information Processing, Artificial Intelligence, Machine Learning, Quantum Cryptography, Quantum Chemistry, Pattern Recognition, Quantum Operating System, and Quantum Random Number Generation

39 similar entities Type: Startup Activities: it services deeptech Technologies: Cybersecurity A.I. A.I. - Machine Learning A.I. - Natural Language Processing

#empoweringGameChangers redalpine is the pan-European venture capital firm that empowers GameChangers. Founded in Switzerland in 2006, redalpine brings together financial investment, operational expertise, and a vast international network to help ambitious entrepreneurs transform their vision into a reality. With over €1bn in assets under management and a disciplined, sector-agnostic investment strategy, the firm has backed some of Europe’s most disruptive companies, including N26, Mistral AI, Proxima Fusion, Klarna, Taxfix, Inkitt, 9fin, and vivenu. redalpine has over 100 companies in its portfolio and invests Europe-wide from its offices in Zurich, Berlin, and London. Venture Capital, Startup Financing, Internet, and Life Science

Type: Incubators & VCs

Finding the right clinical trial has never been easier! Klineo is the innovative platform that finally offers intuitive and intelligent clinical trial searching for oncology patients and doctors.

Type: Startup Activities: healthtech deeptech Technologies: SaaS

We’re tackling aging with the power of a global community. VitaDAO is a decentralized, community-owned collective dedicated to funding and advancing early stage longevity science research. Our mission is to support researchers who are working to pre-empt the onset of age-related diseases, and to bring new therapeutics to market that allow people to live longer, healthier lives.

Type: Incubators & VCs Activities: deeptech biotech

Our ambition is to offer each patient personalized and comprehensive care. The ICM, Montpellier Regional Cancer Institute, is one of the 18 Cancer Centers (CLCC) in the Unicancer network. A Private Health Establishment of Collective Interest (ESPIC), providing a public hospital service and recognized as being of public utility, the ICM is the center of reference and excellence at the regional level in cancer research and in the care of patients with cancer. All ICM staff, like all CLCCs, share common values ​​to offer optimal care to our patients: humanism, excellence, solidarity, innovation. #EmployerBrand #QualityOfLifeAtWork #QVT #Innovation #Recruitment #Recruiter #Sourcing …

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech

Pureos is a venture capital fund investing in private innovative drug development companies Pureos Bioventures is a venture capital fund, which invests exclusively in private innovative drug development companies, with a special emphasis on the next generation of biological drugs and drug formats. The fund’s portfolio companies are built on scientific excellence to develop therapies across a broad indication spectrum including oncology, immunology, ophthalmology, rare diseases, and neuroscience. Pureos has built a team with deep investment, operating and clinical expertise, that strives to impact patients’ lives by advancing innovative treatments for devastating diseases.

Type: Incubators & VCs

Switzerland's leading startup competition »venture» is an initiative of the ETH Zurich, McKinsey & Company, Switzerland, Knecht Holding, the innovation promotion agency CTI and EPFL Lausanne. As the leading Swiss-wide competition for the best business idea and the best business plan, »venture» supports young entrepreneurs in founding a company. The competition aims to unleash untapped innovation potential by encouraging young entrepreneurs to develop a business idea. A number of renowned companies from Swiss industry and commerce sponsor the competition. Experienced coaches support competition participants in the development of their business idea, the preparation of their business plans, and in the …

Tags: H2020 Type: Incubators & VCs

Wir schaffen Wissen – heute für morgen The Paul Scherrer Institute PSI develops, builds and operates large, complex research facilities and makes them available to the national and international research community. The institute's own key research priorities are in the fields of future technologies, energy and climate, health innovation and fundamentals of nature. PSI is committed to the training of future generations. Therefore, about one quarter of our staff are post-docs, post-graduates or apprentices. Altogether, PSI employs 2200 people, thus being the largest research institute in Switzerland. The annual budget amounts to approximately CHF 400 million. PSI is part of …

Type: Public

Europe’s premier digital media platform for the global biotech industry. Labiotech.eu is Europe’s premier digital media platform for the global biotech industry. More than 130,000 monthly biopharma readers rely on Labiotech for insights into the latest innovations in biotechnology and our analysis of a dynamic industry. Subscribe today for access to our daily articles, in-depth content and extensive archive. Biotechnology, Life science, News, and Media

Type: Media

Building bridges between Japan and the Bay Area since 1905. The Japan Society of Northern California is an educational non-profit organization and the West Coast’s leading forum on Japan and US-Japan relations. Its mission is to strengthen cooperation and understanding between the peoples of the United States and Japan in a changing world by providing programs that help to expand knowledge, increase personal interaction and facilitate discussion of important issues. Ever since our founding in 1905, the Japan Society has believed in the power of knowledge and personal contact to bring peoples and countries together. Now, more than 100 years …

Type: NGO, Think-tanks, Ed, & Culture Activities: edtech

Live Locally, Grow Globally A national university located in Osaka, Japan, and founded in 1931, with roots going back as far as 1838 and the establishment of the private "place of learning," Tekijuku, Osaka University is a premier research university not only in Japan but globally as well. With 11 undergraduate schools, 15 graduate schools, two university hospitals, as well as a number of research institutes and joint-use facilities (including the World Premier International Research Center Initiative's Immunology Frontier Research Center) spread over 3 campuses, Osaka University is well-equipped to meet the research needs of the modern era. Osaka University …

Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech

Molecular and Developmental Biology Contributing to a better world through research into the fundamental processes of living cells, tissues and organisms. We aim to be a connective institute where curiosity-driven research of molecular and developmental biology trains future science leaders and fuels biomedical innovations. The Hubrecht Institute is a research institute of the Royal Netherlands Academy of Arts and Sciences (KNAW) and is affiliated with the UMC Utrecht.

Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech

Working towards a future where no one dies prematurely from NCDs and all have access to prevention, treatment and care. Access Accelerated is an initiative that brings together leading biopharmaceutical and life science companies committed to tackling the growing burden of non-communicable diseases (NCDs) in low- and middle-income countries. Together with partners from across the global biopharmaceutical sector, multilateral organizations and non-governmental organizations, Access Accelerated works toward a future where no one dies prematurely from treatable, preventable diseases. Launched in 2017, the initiative works to identify and break down barriers to NCD prevention, treatment and care by uniting the efforts …

Type: NGO, Think-tanks, Ed, & Culture Activities: cleantech

We are the leading ecosystem for next generation healthcare – we partner, enable, and connect. Flying Health is the leading ecosystem for next generation healthcare – we partner, enable, and connect. Within our ecosystem, we build bridges between startups, corporates, and relevant stakeholders, transforming industry leaders and entrepreneurs into healthcare pioneers. Our work combines long-standing consulting expertise and innovative trend research that enable closing the gap between healthcare and technological innovation. Together with our partners, we create strategies, business models, and networks that shape the future of healthcare. Digital Health, Incubator, Startups, Internetmedizin, Medical ecosystem, Software as a drug, Digital …

35 similar entities Type: SMB Activities: healthtech entrepreneurship fintech deeptech Technologies: SaaS

London-based venture fund investing in advanced therapies 4BIO Capital is an international venture capital firm focused solely on the advanced therapies sector. 4BIO’s objective is to invest in, support, and grow early stage companies developing treatments in areas of high unmet medical need, with the ultimate goal of ensuring access to these potentially curative therapies for all patients. Specifically, it looks for viable, high-quality opportunities in cell and gene therapy, RNA-based therapy, targeted therapies, and the microbiome. The 4BIO team comprises leading advanced therapy scientists and experienced life science investors who have collectively published over 250 scientific articles in prestigious …

Type: Incubators & VCs

The Singapore Economic Development Board (EDB), the lead government agency under the Ministry of Trade and Industry, is responsible for strategies that enhance Singapore’s position as a global centre for business, innovation, and talent. Our mission is to create sustainable economic growth, with vibrant business and good job opportunities for Singapore. Our House Rules: We aim to bring you the latest news, stories and developments around Singapore's businesses and economy. We welcome your active participation in meaningful and constructive conversations around our content. To keep this a pleasant environment for all, we urge all friends and fans to abide by …

Type: Public